NSGC 2026 has ended. This guide stays up as the record of who was there. Next: NSGC 2027, Nov 7–11, 2027 in Tampa
Acadia Pharmaceuticals at NSGC 2026
Nov 10–14, 2026 Baltimore, MD ~2.5k attendees Website
Acadia Pharmaceuticals takes part in 1 session at NSGC 2026 in Baltimore, and exhibits at Booth 963. Its breakfast symposium covers managing Rett syndrome with DAYBUE and DAYBUE STIX, the two forms of the company's FDA-approved treatment for the condition. Acadia Pharmaceuticals also has an approved medicine for Parkinson's disease psychosis and is developing more for neurological and rare conditions.
| Organization | NSGC 2026 Attendance |
|---|---|
Acadia Pharmaceuticals San Diego, CA | |
Biopharmaceutical company with approved treatments for Rett syndrome and Parkinson's disease psychosis, developing further medicines for neurological and rare conditions. | Booth Exhibiting at Booth 963 Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm Symposium Fri Nov 13 7:45–8:30am Rett Syndrome Management Your Way: Two Formulations of the First and Only FDA-Approved Treatment Covers Rett syndrome care with both forms of Acadia's FDA-approved Rett treatment, DAYBUE and DAYBUE STIX. |
Find decision makers at Acadia Pharmaceuticals
Tell us what you sell and we’ll find the people at Acadia Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the National Society of Genetic Counselors (NSGC). Organization details are derived from NSGC’s published exhibitor list and program, and each organization’s own website. Submit a correction